Related Experiment Videos
[Drug intolerance]
Terapevticheskii Arkhiv
|January 1, 1996
Summary
Drug intolerance impacts neutrophil chemiluminescence, a key indicator of immune response. This study reveals how chemiluminescence tests can identify inadequate blood cell reactions to drugs, aiding in diagnosis and monitoring patient recovery.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Drug intolerance is a growing clinical concern.
- Neutrophil chemiluminescence is a sensitive measure of oxidative burst activity.
- Assessing blood cell response to drugs can reveal underlying intolerance mechanisms.
Purpose of the Study:
- To investigate the utility of luminol-dependent neutrophil chemiluminescence in diagnosing drug intolerance.
- To characterize changes in chemiluminescence patterns associated with drug intolerance reactions.
- To evaluate the chemiluminescence test's potential for monitoring patient recovery from drug intolerance.
Main Methods:
- Experimental analysis of luminol-dependent neutrophil chemiluminescence in blood samples from drug-intolerant patients.
- Testing blood cell reactivity against a range of drugs.
- Comparing chemiluminescence intensity in acute and recovery phases of intolerance.
Main Results:
- A significant decrease in neutrophil and whole blood chemiluminescence intensity was observed in the presence of intolerated drugs.
- In the acute phase, blood cells showed heightened reactivity to various drugs, indicating inadequate responses and altered active oxygen form generation.
- As patients improved, the spectrum of drugs causing decreased chemiluminescence narrowed, with persistently low ratios for specific intolerated drugs.
Conclusions:
- Luminol-dependent neutrophil chemiluminescence serves as a valuable diagnostic tool for drug intolerance.
- The test can differentiate between adequate and inadequate blood cell responses to drugs.
- Chemiluminescence testing can aid in monitoring treatment efficacy and patient recovery in drug intolerance cases.